AARS1-mediated lactylation of STAT1 drives immune evasion
Cell Reports · 2026-03 · 45 (3) · 117094
DOI: 10.1016/j.celrep.2026.117094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-03. Verfasst von Yu Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Zhongsha…. Hauptthemen laut MEDLINE: STAT1 Transcription Factor, Immune Evasion. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, Shanghai Rising-Star Program, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Lactate accumulates in large amounts in tumor cells due to the Warburg effect. However, the role of lactate-mediated lactylation, a post-translational modification, in regulating tumor immunity remains unclear. Here, we report that lactate-driven lactylation of STAT1 K193 inhibits interferon (IFN)-γ signaling pathway-mediated tumor immunity. Mechanistically, AARS1 lactylates STAT1 K193 and inhibits its binding to JAK2 and phosphorylation, thereby disrupting tumor responsiveness to IFN-γ, which leads to a reduction in the expression of downstream chemokines, including CXCL9, CXCL10, and CXCL11, ultimately facilitating immune escape of the tumor. Furthermore, we developed a cell-penetrating peptide, K193-pe, that can competitively inhibit STAT1 K193 lactylation and re-sensitize tumor cells to IFN-γ signaling, thus enhancing CD8+ T cell recruitment and improving the efficacy of immune checkpoint blockade therapy. Collectively, this study elucidates the functional significance of STAT1 K193 lactylation in tumor immunity and suggests that targeted inhibition of this modification, when paired with immunotherapy, may offer a viable treatment strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Tongji Hospital,…
- Tongji Hospital, Frontier Science Center for Stem Cell Research, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
- Department of Gastroenterology, Tongji Institute of Digestive Disease, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
- MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic addre…
- Tongji Hospital, Frontier Science Center for Stem Cell Research, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China. Electronic a…
Förderung
- National Key Research and Development Program of China Stem Cell and Translational Research
- Shanghai Rising-Star Program
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Program for Professor of Special Appointment Eastern Scholar at Shanghai Institutions of Higher Learning
- National Key Research and Development Program of China
Zitieren
APA
Du, Y., He, M., Xu, Y., Tian, T., Zhou, Y., Zhang, Y., Fu, H., Li, J., Lv, L., & Xu, Y. (2026). AARS1-mediated lactylation of STAT1 drives immune evasion. Cell Reports, 45(3), 117094. https://doi.org/10.1016/j.celrep.2026.117094
Vancouver
Du Y, He M, Xu Y, Tian T, Zhou Y, Zhang Y, et al. AARS1-mediated lactylation of STAT1 drives immune evasion. Cell Reports. 2026;45(3):117094. doi:10.1016/j.celrep.2026.117094
BibTeX
@article{Du2026,
author = {Du, Yu and He, Meilin and Xu, Yixin and Tian, Tongguan and Zhou, Yuefan and Zhang, Yan and Fu, Haifei and Li, Jiaxi and Lv, Lei and Xu, Yanping},
title = {AARS1-mediated lactylation of STAT1 drives immune evasion},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {3},
pages = {117094},
doi = {10.1016/j.celrep.2026.117094}
}
EUVIMED